• Radiobiology of alpha emitters : development of an in vitro tumor model of targeted alpha-therapy
    Jacquet C, Oger R, Gouard S, Eychenne R, Maingueneau C, Ligeour M, Guérard F, Chérel M, Gaschet J, Guilloux Y, Allard M
    15th Workshop New modalities in Cancer Imaging and Therapy, Erquy, France, 5-8 octobre 2022

  • Locoregional Astatine-211 Radioimmunotherapy Targeting Syndecan-1 in a Syngeneic Glioblastoma Mouse Model
    Roncali L, Roy C, Marionneau-Lambot S, Gouard S, Eychenne R, Avril S, Guérard F, Hindré F, Chérel M, Garcion E
    15th Workshop New modalities in Cancer Imaging and Therapy, Erquy, France, 5-8 octobre 2022

  • Study of radiolabeled hepatotropic peptide derivatives for the diagnosis and treatment of hepatocellular carcinoma
    Nahas H, Brossard C, Vene E, Gouard S, Chérel M, Bourgeois M, Loyer P, Lepareur N, Cammas-Marion S
    15th Workshop New modalities in Cancer Imaging and Therapy, Erquy, France, 5-8 octobre 2022

  • Novel Positron Emission Tomography with Opaque Liquid Scintillator Detection Technology
    Hourlier A, Bongrand M, Bourgeois C, Brasse D, Breton D, Briere M, Cabrera A, Chaumat V, Dahmane A, Gazzini R, Giovagnoli D, Haddad F, Hull G, Lanièce P, Lefevre F, Loaiza P, Maalmi J, Mellak Y, merlin T, Mastrippolito R, Marquet C, Ménard L, navas-Nicolas D, Pillot P, Simard L, Stocco D, Verdier MA, Visvikis D, Yermia F
    15th Workshop New modalities in Cancer Imaging and Therapy, Erquy, France, 5-8 octobre 2022

  • La ligne de faisceau d’Arronax pour les études précliniques
    Koumeir C
    AG du GDR MI2B, Orsay, France, 13-15 juin 2022